NeuroMetrix Receives FDA 510(k) Clearance for Advance

Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat […]

Read more »

[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies

ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on […]

Read more »

Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth

The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade […]

Read more »

Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove

Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 […]

Read more »

Biophan Moves Forward with Myotech CSS Development

Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and […]

Read more »

OccuLogix Looks to Tears, Hopes to Survive Difficulties

OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose […]

Read more »

Maryland Medicaid Approves ActiPatch Technology for Kidney Compromised Patients

Patients with kidney disease often avoid common pain relievers like aspirin, ibuprofen and naproxen. These medications have the potential to […]

Read more »

[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct

Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, […]

Read more »

CryoLife to Distribute Medafor Hemostatic Agent

CryoLife, in a three-year agreement signed last week, will become the exclusive U.S. distributor of Minneapolis, MN-based Medafor’s microporous polysaccharide […]

Read more »

Boston Scientific to Acquire CryoCor

Boston Scientific will acquire CryoCor for $17.6 million in cash or $1.35 per share. The buyout comes after a tumultuous […]

Read more »